Bernadette Porter

884 total citations
32 papers, 550 citations indexed

About

Bernadette Porter is a scholar working on Pathology and Forensic Medicine, Hematology and Neurology. According to data from OpenAlex, Bernadette Porter has authored 32 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 7 papers in Hematology and 6 papers in Neurology. Recurrent topics in Bernadette Porter's work include Multiple Sclerosis Research Studies (20 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Urinary Tract Infections Management (4 papers). Bernadette Porter is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Urinary Tract Infections Management (4 papers). Bernadette Porter collaborates with scholars based in United Kingdom, United States and Slovenia. Bernadette Porter's co-authors include Alan J. Thompson, Jalesh N. Panicker, Siobhan M Leary, Jeremy Chataway, Clare J. Fowler, Anne North, Sheilagh Reid, Mandy Wells, Marcus J. Drake and Michael Kirby and has published in prestigious journals such as PLoS ONE, The Lancet Neurology and Journal of the Neurological Sciences.

In The Last Decade

Bernadette Porter

29 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernadette Porter United Kingdom 11 304 171 161 108 98 32 550
W. Keith Yeates United Kingdom 9 111 0.4× 102 0.6× 155 1.0× 23 0.2× 26 0.3× 20 397
M.G. Lucas United Kingdom 14 128 0.4× 362 2.1× 357 2.2× 50 0.5× 108 1.1× 29 746
Johana Béné France 12 194 0.6× 168 1.0× 12 0.1× 16 0.1× 51 0.5× 34 591
Seyedeh Tahereh Faezi Iran 16 93 0.3× 355 2.1× 7 0.0× 16 0.1× 35 0.4× 59 639
Hélène Béhal France 13 85 0.3× 35 0.2× 7 0.0× 40 0.4× 44 0.4× 35 388
Bülent Hacıhamdioğlu Türkiye 15 95 0.3× 23 0.1× 20 0.1× 11 0.1× 91 0.9× 54 564
A. L. Dolan United Kingdom 13 156 0.5× 247 1.4× 4 0.0× 36 0.3× 68 0.7× 17 681
Jonathan M. Vapnek United States 17 47 0.2× 322 1.9× 382 2.4× 18 0.2× 123 1.3× 25 667
Kwong Ng Singapore 14 97 0.3× 37 0.2× 29 0.2× 13 0.1× 31 0.3× 36 494
George T. Klauber United States 16 33 0.1× 199 1.2× 375 2.3× 17 0.2× 74 0.8× 41 838

Countries citing papers authored by Bernadette Porter

Since Specialization
Citations

This map shows the geographic impact of Bernadette Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernadette Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernadette Porter more than expected).

Fields of papers citing papers by Bernadette Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernadette Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernadette Porter. The network helps show where Bernadette Porter may publish in the future.

Co-authorship network of co-authors of Bernadette Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Bernadette Porter. A scholar is included among the top collaborators of Bernadette Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernadette Porter. Bernadette Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Vivien, Carmel Curtis, Bernadette Porter, et al.. (2020). The prevention and management of hospital admissions for urinary tract infection in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 45. 102432–102432. 5 indexed citations
2.
John, Nevin, Vivien Li, Bernadette Porter, et al.. (2019). Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm. Journal of the Neurological Sciences. 407. 116456–116456. 3 indexed citations
3.
Chataway, Jeremy, et al.. (2017). Timely relapse treatment in multiple sclerosis: health utility analysis of the NeuroDirect integrated pathway. British Journal of Neuroscience Nursing. 13(4). 160–169. 1 indexed citations
4.
Phé, V., Mahreen Pakzad, Collette Haslam, et al.. (2016). An open label feasibility study evaluating D-Mannose for the prevention of urinary tract infections in patients with multiple sclerosis. Neurourology and Urodynamics.
5.
Phé, V., Mahreen Pakzad, Carmel Curtis, et al.. (2016). Urinary tract infections in multiple sclerosis. Multiple Sclerosis Journal. 22(7). 855–861. 43 indexed citations
6.
Rakuša, Martin, Stefan Cano, Bernadette Porter, et al.. (2015). A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses. PLoS ONE. 10(3). e0120829–e0120829. 6 indexed citations
7.
Porter, Bernadette, et al.. (2015). The role of the MS clinical nurse specialist in the management of disease-modifying drugs. British Journal of Neuroscience Nursing. 11(6). 272–278. 1 indexed citations
8.
Rakuša, Martin, Olwen C. Murphy, Lauren M. McIntyre, et al.. (2012). Testing for urinary tract colonization before high‐dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation. European Journal of Neurology. 20(3). 448–452. 25 indexed citations
9.
Riazi, Afsane, Bernadette Porter, Jeremy Chataway, Alan J. Thompson, & Jeremy Hobart. (2011). A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS). Health and Quality of Life Outcomes. 9(1). 80–80. 4 indexed citations
10.
Fowler, CJ, M. E. Drake, Colleen Harris, et al.. (2009). A UK consensus on the management of the bladder in multiple sclerosis (Reprinted from Journal of Neurology, Neurosurgery, and Psychiatry, vol 80, pg 470-7, 2009). UCL Discovery (University College London). 8 indexed citations
11.
Fowler, Clare J., Jalesh N. Panicker, Marcus J. Drake, et al.. (2009). A UK consensus on the management of the bladder in multiple sclerosis. Postgraduate Medical Journal. 85(1008). 552–559. 204 indexed citations
12.
Freeman, Jennifer, Bernadette Porter, & Alan J. Thompson. (2008). Neurorehabilitation in Multiple Sclerosis. Topics in Spinal Cord Injury Rehabilitation. 14(2). 63–75. 3 indexed citations
13.
Porter, Bernadette, et al.. (2006). IV steroids for MS relapse: clinical governance implications. British Journal of Nursing. 15(13). 716–721. 1 indexed citations
14.
Chataway, Jeremy, Bernadette Porter, Afsane Riazi, et al.. (2006). Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. The Lancet Neurology. 5(7). 565–571. 35 indexed citations
15.
Porter, Bernadette, et al.. (2004). A nurse-led, patient-centred mitoxantrone service in neurology. British Journal of Nursing. 13(17). 1021–1023. 3 indexed citations
16.
Riazi, Afsane, JC Hobart, Bernadette Porter, Jeremy Chataway, & Alan J. Thompson. (2003). Developing a measure of patients' experiences of relapse management in multiple sclerosis.. UCL Discovery (University College London). 1 indexed citations
17.
Porter, Bernadette, et al.. (2003). Disease-modifying drugs in multiple sclerosis. Nursing Standard. 17(50). 39–45. 7 indexed citations
18.
Porter, Bernadette. (2002). The Role of the Advanced Practice Nurse in Anticoagulation. AACN Clinical Issues Advanced Practice in Acute & Critical Care. 13(2). 221–233. 6 indexed citations
19.
Reiss, R A, et al.. (2002). Point‐of‐Care versus Laboratory Monitoring of Patients Receiving Different Anticoagulant Therapies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(6). 677–685. 16 indexed citations
20.
Leary, Siobhan M, et al.. (2001). Managing Spasticity in People With Multiple Sclerosis: A Goal-Oriented Approach to Intrathecal Baclofen Therapy. International Journal of MS Care. 3(4). 10–25. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Keith Yeates Breakdown of academic impact, for papers by M.G. Lucas Breakdown of academic impact, for papers by Johana Béné Breakdown of academic impact, for papers by Seyedeh Tahereh Faezi Breakdown of academic impact, for papers by Hélène Béhal Breakdown of academic impact, for papers by Bülent Hacıhamdioğlu Breakdown of academic impact, for papers by A. L. Dolan Breakdown of academic impact, for papers by Jonathan M. Vapnek Breakdown of academic impact, for papers by Kwong Ng Breakdown of academic impact, for papers by George T. Klauber
Rankless by CCL
2026